VANCOUVER, Jan. 22, 2020 /CNW/ – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that the final toxicology test, a Human Repeated Insult Patch Test (“HRIPT”), has successfully been completed. Sirona is...
SYDNEY, Jan 22, 2020 – (ACN Newswire) – Novotech CRO, the largest biotech CRO in Asia Pacific, says the region has had a record year for clinical trials in terms of the numbers of studies, experienced world-class sites and investigators, and patient...
Biocartis Enters into Master Collaboration Agreement with AstraZeneca and Initiates EGFR Liquid Biopsy Study Mechelen, Belgium, 22 January 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART),...
NEW YORK, Jan. 22, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced the completion of patient...
Phesi, a data-driven provider of premier integrated clinical development analytics products and services, today announced that OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS) has purchased a multi-year ClinSite™ license to enable more accurate and precise...
Email
Text